Abnormalities in Alzheimer's disease fibroblasts bearing the APP670/671 mutation

Neurobiology of Aging

Volumn 18, Issue 6, 1997, Pages 573-580

  Gibson, G E ^a   Vestling, M ^b   Zhang, H ^a   Szolosi, S ^a   Alkon, D ^c   Lannfelt, L ^b   Gandy, S ^a   Cowburn, R F ^b  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b KAROLINSKA INSTITUTE   (Sweden)

^c NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

ketoglutarate dehydrogenase; Alzheimer's disease; Amyloid precursor protein; Bombesin; Bradykinin; Calcium; Fibroblasts; Signal transduction

Indexed keywords

AMYLOID PRECURSOR PROTEIN; BOMBESIN; BRADYKININ; CALCIUM; OXOGLUTARATE DEHYDROGENASE;

AEROBIC METABOLISM; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; FIBROBLAST; GENE MUTATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; BOMBESIN; BRADYKININ; CALCIMYCIN; CALCIUM; FIBROBLASTS; HUMANS; IONOPHORES; KETOGLUTARATE DEHYDROGENASE COMPLEX; MITOCHONDRIA; MUTATION; SIGNAL TRANSDUCTION;

EID: 0031470172     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-4580(97)00149-8     Document Type: Article

References (46)

1. Axelman K., Basun H., Winblad B., Lannfelt L. A large Swedish family with Alzheimer's disease with a codon 670/671 amyloid precursor protein mutation A clinical and genealogical investigation . Arch. Neurol. 51:1994;1193-1197.
2. Blass, J. P.; Sheu, K. -F. R.; Piaciantini, S.; Sorbi, S. Inherent abnormalities in oxidative metabolism in AD: Interaction with vascular abnormalities. In: de la Torre, J. C.; Hachinski, V. eds. Cerebrovasular Pathology in Alzheimer's Disease. New York: New York Academy of Sciences; 1997 (In press).
3. Bruel A. G., Cherqui G., Columelii S., Margelin D., Roudier M., Sinet P., Prieur M., Perignon J., Delarab J. Reduced protein kinase C activity in sporadic Alzheimer's disease fibroblasts. Neurosci. Lett. 133:1991;89-92.
4. Citron M., Vigo-Pelfrey C., Teplow D. B., Miller C., Schenk D., Johnston J., Winblad B., Venizelos N., Lannfelt L., Selkoe D. J. Excessive production of amyloid beta-protein by peripheral cells of symptomatic and presymptomatic patients carrying the Swedish familial Alzheimer disease mutation. Proc. Natl. Acad. Sci. USA. 91:1994;11993-11997.
5. Cristofalo V. J., Charpentier R. A standard procedure for cultivating human diploid fibroblast like cells to study cellular aging. J. Tiss. Cult. Meth. 3117-121.
6. Etcheberrigaray R., Ito E., Oka K., Tofel-Grehl B., Gibson G. E., Alkon D. L. Potassium channel dysfunction in fibroblasts identifies patients with Alzheimer's disease. Proc. Natl. Acad. Sci. USA. 90:1993;8209-8213.
7. + channels. Science. 264:1994;276-279.
8. Gabuzda D., Busciglio J., Chen L. B., Matsudaira P., Yankner B. A. Inhibition of energy metabolism alters the processing of amyloid precursor protein and induces a potentially amyloidogenic derivative. J. Biol. Chem. 269:1994;13623-13628.
9. Gibson, G.; Martins, R.; Blass, J.; Gandy, S. Altered oxidation and signal transduction systems in fibroblasts from Alzheimer patients. In: Mailer, D.; Gispen, W., eds. The Current Status of the Calcium Hypothesis of Brain Aging and Alzheimer's Disease. Life Science 59:477-490; 1996.
10. Gibson G. E., Sheu K-F. R., Blass J. P., Baker A., Carlson K. C., Harding B., Perrino P. Reduced activities of thiamine-dependent enzymes in brains and peripheral tissues of Alzheimer patients. Arch. Neurol. 45:1988;836-840.
11. Gibson G. E., Toral-Barza L., Tofel-Grehl B., Szolosi S., Zhang H. Calcium stores in cultured fibroblasts and their changes with Alzheimer's disease. Biochim. Biophys. Acta. 1316:1996;71-77.
12. Govoni S., Bergamaschi S., Racchi M., Battaini F., Binetti A., Bianchetti A., Trabucchi M. Cytosol protein kinase C down regulation in fibroblasts Alzheimer's disease patients. Neurol. 43:1993;1195-1199.
13. 2+ indicators with greatly improved fluorescence properties. J. Biol. Chem. 260:1985;3440-3450.
14. Guo Q., Katsutosh F., Sopher B. L., Pham D. G., Robinson N., Martin G. M., Mattson M. P. Alzheimer' PS-1 mutation perturbs calcium homeostasis and sensitizes PC12 cells to death induced by amyloid β-peptide. NeuroReport. 8:1996;379-383.
15. Haass C., Lemere C. A., Capell A., Citron M., Seubert P., Schenk D., Lannfelt L., Selkoe D. J. The Swedish mutation causes early-onset Alzheimer's disease by beta-secretase cleavage within the secretory pathway. Nature Med. 1:1995;1291-1296.
16. Hagiwara M., Inagaki M., Kanamura K., Ohta H., Hidaka H. Inhibitory effects of aminoglycosides on renal protein phosphorylation by protein kinase C. J. Pharmacol. Exp. Ther. 244:1988;355-360.
17. 2+ in pyruvate dehydrogenase interconversion in brain mitochondria and synaptosomes. Biochem. J. 227:1985;129-136.
18. Hirashima N., Etcheberrigaray R., Battaini R., Bergamaschi S., Racchi M., Battaini F., Binetti G., Govoni S., Alkon D. L. Calcium responses in human fibroblasts a diagnostic molecular profile for Alzheimer's disease . Neurobiol. Aging. 17:1996;549-555.
19. Hori R., Yamamoto K., Saito H., Kohno M., Inui K. Effect of aminoglycoside antibiotics on cellular functions of kidney epithelial cell line (LLC-PK1) A model system for aminoglycoside nephrotoxicity . J. Pharmacol. Exp. Ther. 230:1984;724-728.
20. Howard M., Frizzell R. A., Bedwell D. M. Aminoglycoside antibiotics restore CFTR function by overcoming premature stop mutations. Nature Med. 2:1996;467-469.
21. Huang, H. -M.; Gibson, G. E. Altered β-adrenergic receptor stimulated cAMP formation in cultured skin fibroblasts from Alzheimer donors. J. Biol. Chem. 268:14616-1462; 1993.
22. Huang H. -M., Lin T. A., Sun G. Y., Gibson G. E. Increased insitol(1,4,5)trisphosphate accumulation correlates with an upregulation of bradykinin receptors in Alzheimer's disease. J. Neurochem. 64:1995;761-766.
23. Huang H. -M., Martins R., Gandy S., Etcheberrigaray R., Ito E., Alkon D. L., Blass J. P., Gibson G. E. The use of cultured fibroblasts in elucidating the pathophysiology and diagnosis of Alzheimer's disease. Disterhoft J. F., Gispen W. H., Traber J., Khachaturian Z. S. Calcium Hypothesis of Aging and Dementia. 1994;225-244 New York Academy of Science, New York.
24. 2+ mobilization is altered in fibroblasts with Alzheimer disease. Proc. Natl. Acad. Sci. USA. 91:1994;534-538.
25. Johnston J. A., Cowburn R. F., Norgren S., Wiehager B., Venizelos N., Winblad B., Vigo-Pelfrey C., Schenk D., Lannfelt L., O'Neill C. Increased beta-amyloid release and levels of amyloid precursor protein (APP) in fibroblast cell lines from family members with the Swedish Alzheimer's disease APP670/671 mutation. FEBS Letters. 354:1994;274-278.
26. Kaido M., Fugimura H., Soga F., Toyooka S. K., Yoshikawa H., Nishimura T., Higashi T., Inui K., Imanishi H., Yorifuji S., Yanagihara T. Alzheimer-type pathology in a patient with mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS). Acta Neuropathol. 92:1996;312-318.
27. Kim C. S., Han Y. F., Etcheberrigaray R., Nelson T. J., Olds J. L., Yoshioka T., Alkon D. L. Alzheimer and beta-amyloid-treated fibroblasts demonstrate a decrease in a memory-associated GTP-binding protein, Cp20. Proc. Natl. Acad. Sci. USA. 92:1995;3060-3064.
28. Kumar U., Dunlop D. M., Richardson J. S. Mitochondria from Alzheimer's fibroblasts show decreased uptake of calcium and increased sensitivity to free radicals. Life Science. 54:1994;1855-1860.
29. Lai J. C., Cooper A. J. Brain alpha-ketoglutarate dehydrogenase complex Kinetic properties, regional distribution, and effects of inhibitors . J. Neurochem. 47:1986;11376-11386.
30. Lannfelt L., Bogdanovic N., Appelgren H., Axelman K., Lilius L., Hansson G., Schenk D., Hardy J., Winblad B. Amyloid precursor protein mutation causes Alzheimer's disease in a Swedish family. Neurosci. Letts. 168:1994;254-256.
31. 2+ homeostasis and cell death . J. Neurosci. 15:1995;6239-6249.
32. 246) familial Alzheimer cells. NeuroReport. 7:1995;217-220.
33. Mattson M. P. Calcium and neuronal injury in Alzheimer's disease Contributions of beta-amyloid precursor protein mismetabolism, free radicals, and metabolic compromise. Ann. NY Acad. Sci. 747:1994;50-76.
34. Mullan M., Crawford F., Axelman K., Houlden H., Lilius L., Winblad B., Lannfelt L. A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N-terminus of beta-amyloid. Nature Genetics. 1:1992;345-347.
35. Peterson C., Gibson G. E., Blass J. P. Altered calcium uptake in cultured skin fibroblasts from patients with Alzheimer's disease. N. Engl. J. Med. 312:1985;1063-1064.
36. Peterson C., Goldman J. Alterations in calcium content and biochemical processes in cultured skin fibroblasts from aged and Alzheimer donors. Proc. Natl. Acad. Sci. USA. 83:1986;2758-2762.
37. Poenie M. Alteration of intracellular fura-2 fluorescence by viscosity A simple correction . Cell Calcium. 11:1990;85-91.
38. Redman R. S., Silinsky E. M. Decrease in calcium currents induced by aminoglycoside antibiotics in frog motor nerve endings. Br. J. Pharm. 113:1994;375-378.
39. Querfurth H. W., Selkoe D. J. Calcium ionophore increases amyloid beta peptide production by cultured cells. Biochem. 33:1994;4550-4561.
40. Querfurth H. W., Wijsman E. M., St. George-Hyslop P. H., Selkoe D. J. Beta APP mRNA transcription is increased in cultured fibroblasts from the familial Alzheimer's disease-1 family. Mol. Brain Res. 28:1995;319-337.
41. Scheuner D., Eckman C., Jensen M., Song X., Citron M., Suzuki N., Bird T. D., Hardy J., Hutton M., Kukull W., Larsson E., Levy-Lahad E., Viitanen M., Peskind E., Poorkaj P., Schellenberg G., Tanzi R., Wasco W., Lannfelt L., Selkoe D., Younkin S. Secreted amyloid β-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. Nature Med. 2:1996;864-869.
42. Sheu K. -F. R., Cooper A. J. L., Koike K., Koike M., Linsday J. G., Blass J. P. Abnormality of the α-ketaglutarate dehydrogenase complex in fibroblasts from familial Alzheimer's disease. Ann. Neurol. 35:1994;312-318.
43. Tatebayashi Y., Massatoshi T., Kashiwagi T., Masayasu O., Kurumadani T., Sekiyama A., Kanayama G., Hariguchi S., Nishimura T. Cell-cycle dependent abnormal calcium responses in fibroblasts from patients with familial Alzheimer's disease. Dementia. 6:1995;9-16.
44. VanHuynh T., Cole G., Katzman R., Huang K. P., Saitoh T. Reduced protein kinase C immunoreactivity and altered protein phosphorylationin Alzheimer's disease fibroblasts. Arch. Neurol. 46:1989;1195-1199.
45. Vestling, M.; Adem, A.; Lannfelt, L.; Cowburn, R. F. Protein kinase C levels and activity in cultured skin fibroblasts from affected and nonaffected of the Swedish family with the amyloid precursor protein 670/671 mutation. Soc. Neurosci. Abst. 25:744.14; 1995.
46. Vestling M., Adem A., Racchi M., Govoni S., Lannfelt L., Gibson G. E., Cowburn R. F. Differential regulation of adenylyl cyclase activity in fibroblasts from sporadic and familial Alzheimer's disease cases with PS-1 and Swedish APP mutations. Neuroreport. 8:1997;2031-2035.